Compare TG Therapeutics Inc (TGTX) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Xcel Energy Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Xcel Energy Inc trades at $79 (market cap $49.11B). The key difference: Xcel Energy Inc is far larger — about 5.9× TG Therapeutics Inc's market cap, and Xcel Energy Inc pays a 3.01% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | XEL | |
|---|---|---|
Market Cap | $8.26B | $49.11B |
Sector | Health | Utilities |
52-Week High | $59.06 | $83.91 |
52-Week Low | $26.39 | $71.14 |
Enterprise Value | $8.50B | $86.55B |
Dividend Yield | — | 3.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
